3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production.
Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined track record of 40 years in process development and analytical methods development, complemented by our experience in process scale-up, GMP manufacturing, and commercial supply, we are equipped to offer comprehensive manufacturing services at all stages, encompassing Drug Substance and Drug Product.
Our manufacturing sites in Pamplona, Spain, and Turku, Finland seamlessly support the diverse needs of our clients, covering pre-clinical and clinical supply to full-scale commercial manufacturing.
Services
• Plasmid DNA production
• Cell line development, GMP cell banking and Virus Seed Stock
• Cell bank manufacturing and characterization
• Analytical methods development, qualification, and validation
• Technology transfer, process development and optimization
• Scale-up and cGMP supply for clinical trials
• Process characterization
• Process validation
• Scale-up and cGMP manufacturing
• DS and DP testing and release
• DS and DP stability studies
• Formulation development
• Comparability studies
• Fill and Finish
• Quality Assurance and Quality Control
Biologics
- Monoclonal antibodies
- ADCs
- Recombinant proteins, native proteins, monoclonal antibodies, fusion proteins
- Vaccines
- Biosimilars
Other biological molecules
- Peptides
- Lipids
- Carbohydrates
- Complex molecules
Viral Vectors
- AAV
- Adenovirus
Plasmid DNA
Cell Therapy
3P Biopharmaceuticals is the first Spanish CMO that offers full service to develop and manufacture processes and products of Advanced Therapy.
Our staff in the Cell Therapy Department have broad knowledge and know-how in stem cells from human bone marrow, adipose tissue, cornea, and somatic cells such as osteoblasts, chondrocytes, ephitelial and endothelial cells, and other cell populations (hybridomas and tumor cells). Experience in fields as:
- Ophthalmology.
- Orthopedia.
- Cardiology.
- Oncology, etc.
Advanced Therapy Medicinal Products
- Cell therapy products
- Tissue engineered products
Intermediate products:
- Cell culture media
- Biomaterials (scaffolds or membranes)
Values
We offer specialized and highly customized services to biotechnology and pharmaceutical companies.
3PBIOVIAN refuerza su equipo directivo con la incorporación de su directora de desarrollo de negocio de Terapias Avanzadas
3PBIOVIAN
3PBIOVIAN recibe el premio Talent Acceleration en los BWB Awards 2024 en Boston
3PBIOVIAN
Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine
3PBIOVIAN
3P Biopharmaceuticals y Biovian se unen para formar 3PBIOVIAN, una CDMO de medicamentos biológicos líder en Europa
3PBIOVIAN
3P Biopharmaceuticals: forjando un legado de innovación y excelencia en biotecnología
3PBIOVIAN
3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis
3PBIOVIAN
3P Biopharmaceuticals lands in the United States
3PBIOVIAN
3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease
3PBIOVIAN
3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease
3PBIOVIAN
3P Biopharmaceuticals avanza en su plan de expansión y adecuación de sus instalaciones
3PBIOVIAN
